BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34505434)

  • 1. [Identification of
    Wang W; Chen D; Piao H
    Se Pu; 2021 Oct; 39(10):1118-1127. PubMed ID: 34505434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet.
    Carril E; Valdecantos MP; Lanzón B; Angulo S; Valverde ÁM; Godzien J; Rupérez FJ
    J Pharm Biomed Anal; 2020 Jan; 178():112958. PubMed ID: 31718984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary and genetic disruption of hepatic methionine metabolism induce acid sphingomyelinase to promote steatohepatitis.
    Alarcón-Vila C; Insausti-Urkia N; Torres S; Segalés-Rovira P; Conde de la Rosa L; Nuñez S; Fucho R; Fernández-Checa JC; García-Ruiz C
    Redox Biol; 2023 Feb; 59():102596. PubMed ID: 36610223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soyasaponin A
    Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
    Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis.
    Kakehashi A; Suzuki S; Ishii N; Okuno T; Kuwae Y; Fujioka M; Gi M; Stefanov V; Wanibuchi H
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transition from fatty liver to NASH associates with SAMe depletion in db/db mice fed a methionine choline-deficient diet.
    Wortham M; He L; Gyamfi M; Copple BL; Wan YJ
    Dig Dis Sci; 2008 Oct; 53(10):2761-74. PubMed ID: 18299981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis.
    Tanaka N; Matsubara T; Krausz KW; Patterson AD; Gonzalez FJ
    Hepatology; 2012 Jul; 56(1):118-29. PubMed ID: 22290395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis.
    Martínez-López N; Varela-Rey M; Fernández-Ramos D; Woodhoo A; Vázquez-Chantada M; Embade N; Espinosa-Hevia L; Bustamante FJ; Parada LA; Rodriguez MS; Lu SC; Mato JM; Martínez-Chantar ML
    Hepatology; 2010 Nov; 52(5):1621-31. PubMed ID: 20815019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis.
    Wang X; Zeldin S; Shi H; Zhu C; Saito Y; Corey KE; Osganian SA; Remotti HE; Verna EC; Pajvani UB; Schwabe RF; Tabas I
    J Hepatol; 2022 Apr; 76(4):910-920. PubMed ID: 34902531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification cholesterol metabolites altered before the onset of nonalcoholic steatohepatitis by targeted metabolomics.
    Shoji S; Maekawa M; Ogura J; Sato T; Mano N
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 May; 1867(5):159135. PubMed ID: 35217199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease.
    Clarke JD; Novak P; Lake AD; Shipkova P; Aranibar N; Robertson D; Severson PL; Reily MD; Futscher BW; Lehman-McKeeman LD; Cherrington NJ
    Dig Dis Sci; 2014 Feb; 59(2):365-74. PubMed ID: 24048683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
    Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
    World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male
    García-Jaramillo M; Lytle KA; Spooner MH; Jump DB
    Metabolites; 2019 Oct; 9(11):. PubMed ID: 31661783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice.
    Depner CM; Traber MG; Bobe G; Kensicki E; Bohren KM; Milne G; Jump DB
    PLoS One; 2013; 8(12):e83756. PubMed ID: 24358308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
    Kessler SM; Simon Y; Gemperlein K; Gianmoena K; Cadenas C; Zimmer V; Pokorny J; Barghash A; Helms V; van Rooijen N; Bohle RM; Lammert F; Hengstler JG; Mueller R; Haybaeck J; Kiemer AK
    Int J Mol Sci; 2014 Apr; 15(4):5762-73. PubMed ID: 24714086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
    Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
    Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ
    Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis
    Fernández-Ramos D; Lopitz-Otsoa F; Delacruz-Villar L; Bilbao J; Pagano M; Mosca L; Bizkarguenaga M; Serrano-Macia M; Azkargorta M; Iruarrizaga-Lejarreta M; Sot J; Tsvirkun D; van Liempd SM; Goni FM; Alonso C; Martínez-Chantar ML; Elortza F; Hayardeny L; Lu SC; Mato JM
    World J Gastroenterol; 2020 Sep; 26(34):5101-5117. PubMed ID: 32982112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD.
    Drummer CIV; Saaoud F; Sun Y; Atar D; Xu K; Lu Y; Shao Y; Johnson C; Liu L; Shen H; Jhala NC; Jiang X; Wang H; Yang X
    J Immunol Res; 2021; 2021():3928323. PubMed ID: 34859106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.